Analysed INVIVYD INC (IVVD:NASDAQ) News Sources
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
01-06-2026
yahoo.com
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
16-06-2026
yahoo.com
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
06-07-2026
yahoo.com
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
01-09-2026
yahoo.com
What is the current price of INVIVYD INC (IVVD:NASDAQ)?
The current price of INVIVYD INC (IVVD:NASDAQ) is $0.8285.
INVIVYD INC (IVVD:NASDAQ) absolute price change since previous trading day?
The absolute price change of INVIVYD INC (IVVD:NASDAQ) since the previous trading day is $0.0025.
INVIVYD INC (IVVD:NASDAQ) percentage price change since previous trading day?
The percentage price change of INVIVYD INC (IVVD:NASDAQ) since the previous trading day is 0.3027%.
What is the most recent average sentiment score for INVIVYD INC (IVVD:NASDAQ)?
The most recent average sentiment score for INVIVYD INC (IVVD:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for INVIVYD INC (IVVD:NASDAQ)?
The most recent sentiment for INVIVYD INC (IVVD:NASDAQ) is .
SEC-8K** Filing Available For INVIVYD INC (IVVD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.